High-Fat Diet Exacerbates Early Psoriatic Skin Inflammation Independent of Obesity: Saturated Fatty Acids as Key Players

被引:124
作者
Herbert, Diana [1 ]
Franz, Sandra [1 ]
Popkova, Yulia [2 ]
Anderegg, Ulf [1 ]
Schiller, Juergen [2 ]
Schwede, Katharina [1 ]
Lorz, Axel [1 ]
Simon, Jan C. [1 ]
Saalbach, Anja [1 ]
机构
[1] Univ Hosp Leipzig, Dept Dermatol Venerol & Allergol, Leipzig, Germany
[2] Univ Leipzig, Inst Med Phys & Biophys, Leipzig, Germany
关键词
IMMUNE-RESPONSE; ADIPOSE-TISSUE; CELLS; MACROPHAGES; ACTIVATION; EPIDEMIOLOGY; PATHOGENESIS; MECHANISMS; SECRETION; CYTOKINES;
D O I
10.1016/j.jid.2018.03.1522
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In obesity, hypertrophic adipocytes secrete high amounts of adipocytokines, resulting in low-grade inflammation amplified by infiltrating proinflammatory macrophages, oxidative stress, hypoxia, and lipolysis. These chronic proinflammatory conditions support the development of type II diabetes and cardiovascular diseases, but the mechanisms of obesity-related exacerbation of inflammatory skin disorders like psoriasis are unclear. In this study, we uncovered dietary saturated fatty acids (SFAs) as major risk factors for the amplification of skin inflammation, independent of obesity-related parameters such as fat mass extension, adipocytokine levels, and glucose homeostasis. Correlation analyses in a cohort of psoriasis vulgaris patients showed that free fatty acid serum level was the only obesity-associated parameter affecting disease severity. Studies in mice with high-fat diet-induced obesity with psoriasiform inflammation confirmed this critical role of free fatty acids. An increase of free fatty acids in healthy, lean mice alone was sufficient to induce an exacerbation of psoriasiform inflammation. In particular, saturated fatty acids sensitize myeloid cells to an increased inflammatory response in answer to proinflammatory stimuli, which in turn augments the activation of keratinocytes. Consequently, reduction of nutritional saturated fatty acids alone diminished the psoriatic phenotype in obese mice. Thus, our findings may open new perspectives for adjuvant dietary measures accompanying anti-inflammatory psoriasis therapies in lean and obese patients.
引用
收藏
页码:1999 / 2009
页数:11
相关论文
共 59 条
[1]   Adipose tissue as an endocrine organ [J].
Ahima, RS ;
Flier, JS .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) :327-332
[2]   Pathogenesis and immunotherapy in cutaneous psoriasis: what can rheumatologists learn? [J].
Alexander, Helen ;
Nestle, Frank O. .
CURRENT OPINION IN RHEUMATOLOGY, 2017, 29 (01) :71-78
[3]   The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies [J].
Armstrong, A. W. ;
Harskamp, C. T. ;
Armstrong, E. J. .
NUTRITION & DIABETES, 2012, 2 :e54-e54
[4]   Current knowledge on psoriasis and autoimmune diseases [J].
Ayala-Fontanez, Nilmarie ;
Soler, David C. ;
McCormick, Thomas S. .
PSORIASIS-TARGETS AND THERAPY, 2016, 6 :7-32
[5]   Psoriasis and metabolic disease: epidemiology and pathophysiology [J].
Azfar, Rahat S. ;
Gelfand, Joel M. .
CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (04) :416-422
[6]   Obesity and Free Fatty Acids [J].
Boden, Guenther .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2008, 37 (03) :635-+
[7]   The pathogenic role of tissue-resident immune cells in psoriasis [J].
Boyman, Onur ;
Conrad, Curdin ;
Tonel, Giulia ;
Gilliet, Michel ;
Nestle, Frank O. .
TRENDS IN IMMUNOLOGY, 2007, 28 (02) :51-57
[8]   Medical consequences of obesity [J].
Bray, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2583-2589
[9]   Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation [J].
Bremmer, Samuel ;
Van Voorhees, Abby S. ;
Hsu, Sylvia ;
Korman, Neil J. ;
Lebwohl, Mark G. ;
Young, Melodie ;
Bebo, Bruce F., Jr. ;
Blauvelt, Andrew .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (06) :1058-1069
[10]   Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? [J].
Calder, Philip C. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (03) :645-662